Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Cristcot
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
Details : Hydrocortisone Acetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Ulcerative Proctitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 14, 2020
Lead Product(s) : Hydrocortisone Acetate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Cristcot
Deal Size : Inapplicable
Deal Type : Inapplicable